Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1
Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
The Journal of Organic Chemistry
|
October 30, 2019
Multiple Synthetic Routes to the Mini-Protein Omomyc and Coiled-Coil Domain Truncations
Zachary Z Brown, Claudio Mapelli, Iman Farasat, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
Brandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors
Brian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
Xiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Journal of Medicinal Chemistry
|
March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer
Wonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Science (New York, N.Y.)
|
August 22, 2020
An orally available non-nucleotide STING agonist with antitumor activity
Bo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux, et al.
ACS Medicinal Chemistry Letters
|
July 14, 2026
Discovery of MK-2118, a Small-Molecule Agonist of STING
Timothy Henderson, Michael D Altman, Alexei V Buevich, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1
Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
The Journal of Organic Chemistry
|
October 30, 2019
Multiple Synthetic Routes to the Mini-Protein Omomyc and Coiled-Coil Domain Truncations
Zachary Z Brown, Claudio Mapelli, Iman Farasat, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
Brandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors
Brian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
Xiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Journal of Medicinal Chemistry
|
March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer
Wonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Science (New York, N.Y.)
|
August 22, 2020
An orally available non-nucleotide STING agonist with antitumor activity
Bo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux, et al.
ACS Medicinal Chemistry Letters
|
July 14, 2026
Discovery of MK-2118, a Small-Molecule Agonist of STING
Timothy Henderson, Michael D Altman, Alexei V Buevich, et al.
Page
of 2